Arribas M, Roberts I, Chaudhri R, Geer A, Prowse D, Lubeya M
Wellcome Open Res. 2021; 6:157.
PMID: 34250266
PMC: 8264807.
DOI: 10.12688/wellcomeopenres.16884.1.
Yoo J, Ahn J, Karmarkar S, Lamoutte E, Singh K
Ann Transl Med. 2019; 7(Suppl 5):S172.
PMID: 31624738
PMC: 6778277.
DOI: 10.21037/atm.2019.05.36.
Saracoglu A, Ezelsoy M, Saracoglu K
Ir J Med Sci. 2019; 188(4):1373-1378.
PMID: 30815786
DOI: 10.1007/s11845-019-01991-z.
Georgiev G, Tanchev P, Zheleva Z, Kinov P
J Orthop Translat. 2018; 13:7-12.
PMID: 29662786
PMC: 5892384.
DOI: 10.1016/j.jot.2017.12.006.
Altaf M, Stoeckli-Evans H
Acta Crystallogr E Crystallogr Commun. 2017; 73(Pt 10):1421-1425.
PMID: 29250350
PMC: 5730287.
DOI: 10.1107/S2056989017012543.
Management of Blood Loss in Hip Arthroplasty: Korean Hip Society Current Consensus.
Song J, Park J, Lee Y, Kim I, Nho J, Lee K
Hip Pelvis. 2017; 29(2):81-90.
PMID: 28611958
PMC: 5465399.
DOI: 10.5371/hp.2017.29.2.81.
Topical Intravenous Administration of Tranexamic Acid in Primary Total Hip Arthroplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Hanna S, Prasad A, Lee J, Achan P
Orthop Rev (Pavia). 2016; 8(3):6792.
PMID: 27761223
PMC: 5066113.
DOI: 10.4081/or.2016.6792.
Systemic and Topical Use of Tranexamic Acid in Spinal Surgery: A Systematic Review.
Winter S, Santaguida C, Wong J, Fehlings M
Global Spine J. 2016; 6(3):284-95.
PMID: 27099820
PMC: 4836933.
DOI: 10.1055/s-0035-1563609.
Tranexamic acid for the prevention and management of orthopedic surgical hemorrhage: current evidence.
Kim C, Park S, Davey J
J Blood Med. 2015; 6:239-44.
PMID: 26345147
PMC: 4556304.
DOI: 10.2147/JBM.S61915.
Disposition of h-epsilon amino caproic acid and its interaction with adrenergic neurones.
Obianwu H
Br J Pharmacol Chemother. 2008; 31(2):244-52.
PMID: 19108254
PMC: 1557362.
DOI: 10.1111/j.1476-5381.1967.tb01995.x.
Tranexamic acid: a review of its use in surgery and other indications.
Dunn C, Goa K
Drugs. 1999; 57(6):1005-32.
PMID: 10400410
DOI: 10.2165/00003495-199957060-00017.
Basis of antifibrinolytic therapy.
Prentice C
J Clin Pathol Suppl (R Coll Pathol). 1980; 14:35-40.
PMID: 6159375
PMC: 1347103.
Influence of antifibrinolytic substances on allergic reactions. Experiments with epsilon-aminocaproic acid and amino-methyl-cyclohexane-carbonic acid.
RAAB W
Experientia. 1968; 24(3):250.
PMID: 5661420
DOI: 10.1007/BF02152799.
Fibrinolysis and menstrual bleeding.
Br Med J. 1970; 1(5688):61-2.
PMID: 5411443
PMC: 1699151.
Clinical application of inhibitors of fibrinolysis.
Verstraete M
Drugs. 1985; 29(3):236-61.
PMID: 2580684
DOI: 10.2165/00003495-198529030-00003.
